The zealous immune response to injuries is known to cause paralyzing damage in spinal cord injury (SCI).
Engineers have now created unique nanoparticles that redirect immune cells away from the spinal cord, promoting regeneration that helped restore spinal cord function in mice. The study was funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
The spinal cord, similar to the brain, has a blood-brain barrier that guards the fragile nerves against possible damage from numerous assaults; for example, it blocks immune cells from migrating to the site of injury to clean up debris.
This blood-brain barrier gets damaged when a traumatic injury occurs in the spinal cord, and the quick influx of immune cells produces an environment that tries to rapidly shore-up the injury but, at the same time, blocks regenerative processes that can effectively reconstruct and reconnect fragile damaged nerves.
Now, a method has been developed by NIBIB-grantee Lonnie Shea, PhD, the Steven A Goldstein Collegiate Professor, Biomedical engineering, and his coworkers at the University of Michigan in Ann Arbor to overcome this problem.
This technique involves redirecting several immune cells away from the site of injury and simultaneously inducing those cells that do reach the SCI to change to an anti-inflammatory profile. This creates factors that promote a regenerative healing process, which can help restore function.
The novel method has been reported in the July edition of the Proceedings of the National Academy of Sciences.
Image Credit: iStock
News This Week
An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness as a treatment for Covid-19. [...]
New research has shed light on a crucial biological mechanism that may have helped the coronavirus to infect humans and spread rapidly around the world. A detailed analysis of the virus’s structure shows that [...]
How does the COVID-19 pandemic compare to other infamous viral infections that have plagued us in modern times? It’s a question that’s been asked repeatedly in social media circles in recent weeks as people [...]
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
CRISPR gene-edited immune cells have been injected into three people with advanced cancer without any serious side effects, the first trial of its kind in the US. It is also the first CRISPR cancer [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - February 9 2020 Since [...]